Published on in Community Benefit Report
CHOP volunteers make camp a reality for many kids with special medical needs. They not only keep them healthy, but they also take part of the activities and enjoy seeing kids being kids.
Published on in CHOP News
A laboratory study may set the stage for a new preventive treatment for hemophilia patients who now develop antibodies to the standard treatment and then require a bypass therapy.
Published on in CHOP News
CHOP breakthrough helps scientists edge closer to defeating a longtime enemy of human health: hemophilia, the inability to form blood clots.
Published on in CHOP News
A team of gene therapy researchers has reported on a highly active gene variant that achieved sustained factor levels in 10 adults, with no adverse effects.
Published on in CHOP News
Three CHOP researchers recently won grants for their work on hemophilia from the Bayer Hemophilia Awards Program.
Published on in CHOP News, International Update
In a clinical trial led by a CHOP researcher, adult patients with hemophilia B were able to pursue daily activities without disabling bleeds.
Published on in Beyond Blood
Von Willebrand disease (VWD) is a bleeding disorder caused by having too little von Willebrand factor (VWF) protein or VWF that doesn’t work well.
Published on in Beyond Blood
Platelet disorders are an underrecognized cause of bleeding in patients with inherited causes of bleeding. These disorders have only recently become the focus of research efforts.
Published on in Beyond Blood
In response to problems in the U.S. healthcare system, the federal government passed a healthcare reform law called the Patient Protection and Affordable Care Act.
Published on in Beyond Blood
Be aware of the signs of caregiver burnout. It may not be obvious to you, may develop over time, and may not be linked to a specific time or event that you can pinpoint.